Integra LifeSciences Receives FDA Approval for Integra® Omnigraft™ Dermal Regeneration Matrix, Clearing the Way for Commercial Release
May 11, 2016 08:30 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., May 11, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that the Company has...
Integra LifeSciences Provides Update for Omnigraft™ Commercialization Plans, Including Expectations for an Earlier Launch
April 27, 2016 06:00 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., April 27, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that the Company is...
Net Health's Cathy Thomas Hess Defines Best Practices at Annual Skin and Wound Care Clinical Symposium
September 26, 2014 10:38 ET
|
Net Health
PITTSBURGH, Sept. 26, 2014 (GLOBE NEWSWIRE) -- During the 29th Annual Clinical Symposium on Advances in Skin & Wound Care: The Conference for Prevention and Healing, Net Health's Chief Clinical...
Net Health Launches PQRS Reporting Registry for Wound Care Providers
September 25, 2014 15:41 ET
|
Net Health
PITTSBURGH, Sept. 25, 2014 (GLOBE NEWSWIRE) -- Net Health, the leader in software solutions for specialized outpatient care, announced today that the Net Health Specialty Care Registry is accepting...
Kerecis Establishes Scientific Advisory Board of Leading Experts in Wound Care and Surgical Implants
August 08, 2013 12:06 ET
|
Kerecis
REYKJAVIK, ICELAND and ISAFJORDUR, ICELAND--(Marketwired - Aug 8, 2013) - Kerecis Limited, the emerging tissue-regeneration company, today announced the formation of a corporate scientific advisory...
Vista Partners Initiates Coverage on Oculus Innovative Sciences, Inc.; $2.05 Target Price
September 05, 2012 09:15 ET
|
Vista Partners LLC
SAN FRANCISCO, CA--(Marketwire - Sep 5, 2012) - Vista Partners announced today that it has initiated coverage on Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) with a $2.05 target price. Ross...
Minister of Industry Inaugurates Fish Skin Medical Device Facility
September 26, 2011 14:56 ET
|
Kerecis
REYKJAVIK, ICELAND and ISAFJORDUR, ICELAND--(Marketwire - Sep 26, 2011) - Iceland's Minister of Industry Katrin Juliusdottir today inaugurated the Kerecis Medical Device manufacturing facility in...
Kerecis to Present at IN3 East Investor Conference in Boston, June 21 - 23, 2011
June 20, 2011 20:19 ET
|
Kerecis
REYKJAVIK, ICELAND and ISAFJORDUR, ICELAND--(Marketwire - Jun 20, 2011) - Kerecis Limited, the emerging tissue-regeneration company, today announced that its Chairman G. Fertram Sigurjonsson will...